Answers are grounded in this paper and cite their sources.
We present a case of locally advanced pancreatic ductal adenocarcinoma following multi-modality treatment failure, where histotripsy was used as a salvage therapy that was followed by durable disease control. Locally advanced pancreatic ductal adenocarcinoma that progresses despite systemic chemotherapy and radiation carries a poor prognosis and few locoregional treatment options, particularly once cumulative radiation dose to adjacent structures inhibits further irradiation. Histotripsy is a non-thermal, non-ionizing focused-ultrasound technique that mechanically ablates tissue through acoustic cavitation, without ionizing dose, heat, or surgical access. In this case, the patient is a 49-year-old male with locally advanced, unresectable pancreatic ductal adenocarcinoma whose disease progressed through multiple lines of systemic therapy, two courses of radiation including ablative SBRT, and irreversible electroporation which was complicated by life-threatening hemorrhage. He underwent histotripsy as a salvage locoregional therapy, performed in an outpatient setting with prompt resumption of anticoagulation and systemic therapy. Following histotripsy and resumption of chemotherapy, serial imaging showed declining metabolic activity and regression of the histotripsy treatment zone with no new mass at the treated site, and durable local control at 16 months. This case illustrates the feasibility and tolerability of histotripsy as a salvage therapy in multi-modality treatment failure and supports further prospective investigation. To our knowledge, this is one of the first reported uses of histotripsy as a salvage therapy for pancreatic ductal adenocarcinoma after multi-modality treatment failure.
No takes yet. Share an insight, caveat, or question.
Burns et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: